Q-TWiST analysis of survival benefits with brigatinib versus crizotinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer based on results of the ALTA-1L trial
Article in Lung Cancer (September 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Lung Cancer (September 2023)
Article in European Urology Oncology (May 2023)
Article in Cancers (April 2023)